Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery

Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic oncology 2020-05, Vol.38 (5), p.553-554
Hauptverfasser: de Joode, Karlijn, de Ruig-Spakman, Jolanda I., Baktawar, Sarwan S., van Leenders, Geert J.L.H., Verhagen, Paul C.M.S., van der Veldt, Astrid A.M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 554
container_issue 5
container_start_page 553
container_title Urologic oncology
container_volume 38
creator de Joode, Karlijn
de Ruig-Spakman, Jolanda I.
Baktawar, Sarwan S.
van Leenders, Geert J.L.H.
Verhagen, Paul C.M.S.
van der Veldt, Astrid A.M.
description
doi_str_mv 10.1016/j.urolonc.2020.01.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2381841437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078143920300107</els_id><sourcerecordid>2381841437</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-a764e72795c50d572e30a8ec659f1b32e62c401d7f0829cd77afc093adde9d9d3</originalsourceid><addsrcrecordid>eNqFkMluFDEQhi0EIiHwCEE-culO2b24nUuERmxSFC7J2fLY1SOPutuDl5Fy49FxZwaunFyu-mv5P0KuGdQMWH-zr3Pwk19MzYFDDawGkK_IJRtEU_FW9q9LDGKoWNvIC_Iuxj0AawfG3pKLhnNg0MMl-f3gjn7Ks97Sw5QjdQc3ufnlryNd0Gu7z0e9JJoC6jRjidxCD8HNOjxTbUvNoKUBFz1Rg9NEU559iLd0k1Nyy46i3WGkow_UnDLVmqExhx2G5_fkzainiB_O7xV5-vrlcfO9uv_57cfm831lWsZTpUXfouBCdqYD2wmODegBTd_JkW0bjj03LTArRhi4NFYIPRqQjbYWpZW2uSKfTnMPwf_KGJOaXVzv1cVkjoo3AxvaAksUaXeSmuBjDDiqs13FQK3w1V6d4asVvgKmCvzS9_G8Im9ntP-6_tIugruTAIvRo8OgonG48nMBTVLWu_-s-AMF8ZuD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2381841437</pqid></control><display><type>article</type><title>Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>de Joode, Karlijn ; de Ruig-Spakman, Jolanda I. ; Baktawar, Sarwan S. ; van Leenders, Geert J.L.H. ; Verhagen, Paul C.M.S. ; van der Veldt, Astrid A.M.</creator><creatorcontrib>de Joode, Karlijn ; de Ruig-Spakman, Jolanda I. ; Baktawar, Sarwan S. ; van Leenders, Geert J.L.H. ; Verhagen, Paul C.M.S. ; van der Veldt, Astrid A.M.</creatorcontrib><identifier>ISSN: 1078-1439</identifier><identifier>EISSN: 1873-2496</identifier><identifier>DOI: 10.1016/j.urolonc.2020.01.009</identifier><identifier>PMID: 32201060</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Urologic oncology, 2020-05, Vol.38 (5), p.553-554</ispartof><rights>2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-a764e72795c50d572e30a8ec659f1b32e62c401d7f0829cd77afc093adde9d9d3</citedby><cites>FETCH-LOGICAL-c412t-a764e72795c50d572e30a8ec659f1b32e62c401d7f0829cd77afc093adde9d9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1078143920300107$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32201060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Joode, Karlijn</creatorcontrib><creatorcontrib>de Ruig-Spakman, Jolanda I.</creatorcontrib><creatorcontrib>Baktawar, Sarwan S.</creatorcontrib><creatorcontrib>van Leenders, Geert J.L.H.</creatorcontrib><creatorcontrib>Verhagen, Paul C.M.S.</creatorcontrib><creatorcontrib>van der Veldt, Astrid A.M.</creatorcontrib><title>Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery</title><title>Urologic oncology</title><addtitle>Urol Oncol</addtitle><issn>1078-1439</issn><issn>1873-2496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkMluFDEQhi0EIiHwCEE-culO2b24nUuERmxSFC7J2fLY1SOPutuDl5Fy49FxZwaunFyu-mv5P0KuGdQMWH-zr3Pwk19MzYFDDawGkK_IJRtEU_FW9q9LDGKoWNvIC_Iuxj0AawfG3pKLhnNg0MMl-f3gjn7Ks97Sw5QjdQc3ufnlryNd0Gu7z0e9JJoC6jRjidxCD8HNOjxTbUvNoKUBFz1Rg9NEU559iLd0k1Nyy46i3WGkow_UnDLVmqExhx2G5_fkzainiB_O7xV5-vrlcfO9uv_57cfm831lWsZTpUXfouBCdqYD2wmODegBTd_JkW0bjj03LTArRhi4NFYIPRqQjbYWpZW2uSKfTnMPwf_KGJOaXVzv1cVkjoo3AxvaAksUaXeSmuBjDDiqs13FQK3w1V6d4asVvgKmCvzS9_G8Im9ntP-6_tIugruTAIvRo8OgonG48nMBTVLWu_-s-AMF8ZuD</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>de Joode, Karlijn</creator><creator>de Ruig-Spakman, Jolanda I.</creator><creator>Baktawar, Sarwan S.</creator><creator>van Leenders, Geert J.L.H.</creator><creator>Verhagen, Paul C.M.S.</creator><creator>van der Veldt, Astrid A.M.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202005</creationdate><title>Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery</title><author>de Joode, Karlijn ; de Ruig-Spakman, Jolanda I. ; Baktawar, Sarwan S. ; van Leenders, Geert J.L.H. ; Verhagen, Paul C.M.S. ; van der Veldt, Astrid A.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-a764e72795c50d572e30a8ec659f1b32e62c401d7f0829cd77afc093adde9d9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Joode, Karlijn</creatorcontrib><creatorcontrib>de Ruig-Spakman, Jolanda I.</creatorcontrib><creatorcontrib>Baktawar, Sarwan S.</creatorcontrib><creatorcontrib>van Leenders, Geert J.L.H.</creatorcontrib><creatorcontrib>Verhagen, Paul C.M.S.</creatorcontrib><creatorcontrib>van der Veldt, Astrid A.M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Joode, Karlijn</au><au>de Ruig-Spakman, Jolanda I.</au><au>Baktawar, Sarwan S.</au><au>van Leenders, Geert J.L.H.</au><au>Verhagen, Paul C.M.S.</au><au>van der Veldt, Astrid A.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery</atitle><jtitle>Urologic oncology</jtitle><addtitle>Urol Oncol</addtitle><date>2020-05</date><risdate>2020</risdate><volume>38</volume><issue>5</issue><spage>553</spage><epage>554</epage><pages>553-554</pages><issn>1078-1439</issn><eissn>1873-2496</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32201060</pmid><doi>10.1016/j.urolonc.2020.01.009</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-1439
ispartof Urologic oncology, 2020-05, Vol.38 (5), p.553-554
issn 1078-1439
1873-2496
language eng
recordid cdi_proquest_miscellaneous_2381841437
source ScienceDirect Journals (5 years ago - present)
title Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A24%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nivolumab%20plus%20ipilimumab%20as%20neoadjuvant%20treatment%20in%20primary%20advanced%20renal%20cell%20tumors:%20Cutting%20edges%20for%20cutting-edge%20surgery&rft.jtitle=Urologic%20oncology&rft.au=de%20Joode,%20Karlijn&rft.date=2020-05&rft.volume=38&rft.issue=5&rft.spage=553&rft.epage=554&rft.pages=553-554&rft.issn=1078-1439&rft.eissn=1873-2496&rft_id=info:doi/10.1016/j.urolonc.2020.01.009&rft_dat=%3Cproquest_cross%3E2381841437%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2381841437&rft_id=info:pmid/32201060&rft_els_id=S1078143920300107&rfr_iscdi=true